We have shown previously that CD4+ T cells bearing an MHC-I–restricted TCR (F5) can enhance the antitumor activity of CD8+ T cells bearing the same TCR using a model Ag that is tumor-specific and not expressed in normal tissues (17). Here, CD8A is linked to neoplasm.